Search

Search Constraints

You searched for: Date 2019 Author/Creator Uhara, Hisashi

Search Results

1. Adjuvant therapy with nivolumab versus ipilimumab after complete resection of stage III/IV melanoma: Japanese subgroup analysis from the phase 3 CheckMate 238 study. Issue 12 (22nd October 2019)

3. Durable response after cessation of anti‐programmed death 1 therapy in four melanoma patients. Issue 12 (3rd October 2019)

4. Efficacy of combined radiotherapy and anti‐programmed death 1 therapy in acral and mucosal melanoma. Issue 4 (13th February 2019)

6. Japanese real‐world study of sequential nivolumab and ipilimumab treament in melanoma. Issue 11 (17th September 2019)

7. Long‐term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma. Issue 6 (23rd May 2019)